- Home
- NGS vs CADL Comparison
NGS vs CADL Comparison
Compare NGS & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- CADL
- Stock Information
- Founded
- NGS 1998
- CADL 1999
- Country
- NGS United States
- CADL United States
- Employees
- NGS N/A
- CADL N/A
- Industry
- NGS Oilfield Services/Equipment
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- NGS Energy
- CADL Health Care
- Exchange
- NGS Nasdaq
- CADL Nasdaq
- Market Cap
- NGS 282.3M
- CADL 306.4M
- IPO Year
- NGS 2002
- CADL 2021
- Fundamental
- Price
- NGS $22.78
- CADL $8.09
- Analyst Decision
- NGS Strong Buy
- CADL Strong Buy
- Analyst Count
- NGS 2
- CADL 4
- Target Price
- NGS $29.00
- CADL $21.00
- AVG Volume (30 Days)
- NGS 75.2K
- CADL 1.1M
- Earning Date
- NGS 03-17-2025
- CADL 03-13-2025
- Dividend Yield
- NGS N/A
- CADL N/A
- EPS Growth
- NGS 260.53
- CADL N/A
- EPS
- NGS 1.37
- CADL N/A
- Revenue
- NGS $156,742,000.00
- CADL N/A
- Revenue This Year
- NGS $14.76
- CADL N/A
- Revenue Next Year
- NGS $12.00
- CADL N/A
- P/E Ratio
- NGS $16.21
- CADL N/A
- Revenue Growth
- NGS 29.36
- CADL N/A
- 52 Week Low
- NGS $16.70
- CADL $1.45
- 52 Week High
- NGS $29.74
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- NGS 45.43
- CADL 49.50
- Support Level
- NGS $21.36
- CADL $7.85
- Resistance Level
- NGS $22.69
- CADL $8.69
- Average True Range (ATR)
- NGS 0.99
- CADL 0.54
- MACD
- NGS 0.12
- CADL -0.02
- Stochastic Oscillator
- NGS 68.82
- CADL 54.55
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.